CHF 10.04
Key Takeaways
Risk factor
Considerable default risk
Profitability factor
Greatly undervalued vs peers
About
Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA, unde
Target Price
The average target price of MEDX.SW is 19 and suggests 94% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
